Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Quality of Life and Outcomes in Multiple Myeloma Patients

Shilpa Paul, MD, Samith T. Kochuparambil, MBBS, Carrie A Thompson, MD, Tait D. Shanafelt, MD, Francis K Buadi, MD, Martha Q. Lacy, MD, Morie A Gertz, MD MACP, Angela Dispenzieri, MD, David Dingli, MD, PhD, Prashant Kapoor, MD, Suzanne R Hayman, MD, Lisa Hwa, RN, CNP, Jane K Case, P.A.-C, S. Vincent Rajkumar, MD, Shaji Kumar, MD

Blood (2014) 124 (21): 2605.

https://doi.org/10.1182/blood.V124.21.2605.2605

Published: 2014

Journal Articles

Phase 2 Trial Of Single Agent MLN9708 In Patients With Relapsed Multiple Myeloma Not Refractory To Bortezomib

Shaji K Kumar, MD, Vivek Roy, M.D., Craig Reeder, MD, Betsy R. LaPlant, Martha Q Lacy, MD, Morie A Gertz, MD, MACP, Kristina Laumann, Melanie Ann Thompson, Thomas E Witzig, MD, Francis K Buadi, MD, Candido E. Rivera, MD, Joseph R. Mikhael, MD, Peter Leif Bergsagel, MD, Lisa Hwa, RN, CNP, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD

Blood (2013) 122 (21): 1944.

https://doi.org/10.1182/blood.V122.21.1944.1944

Published: 2013

Journal Articles

Therapeutic Strategies For Initial Treatment Of AL Amyloidosis: Implications Of Therapy and Response On Outcome

Anu Paul, MBBS, Angela Dispenzieri, MD, Morie A Gertz, MD, MACP, Martha Q Lacy, MD, Francis K Buadi, MD, Suzanne R Hayman, MD, Nelson Leung, MD, Arleigh McCurdy, MD, Lisa Hwa, RN, CNP, David Dingli, M.D., Ph.D., Prashant Kapoor, MD, Steven R Zeldenrust, MD, PhD, John A Lust, MD, PhD, Stephen Russell, S. Vincent Rajkumar, MD, Shaji K Kumar, MD

Blood (2013) 122 (21): 3343.

https://doi.org/10.1182/blood.V122.21.3343.3343

Published: 2013

Journal Articles

Survival After Second, Third, and Fourth Line Therapy Better Than Expected in Patients with Previously Treated AL Amyloidosis Who Were Not Transplant Candidates At Diagnosis.

Girindra G Raval, MD, Morie A Gertz, Martha Q Lacy, MD, Suzanne R Hayman, MD, Shaji K. Kumar, MD, Francis K Buadi, M.D., John A. Lust, MD, PhD, Steven Zeldenrust, MD, David Dingli, M.D., Ph.D., Robert L Hall, RN, CNP, Lisa Hwa, RN, CNP, Yi Lin, MD, Prashant Kapoor, MD, Thomas E. Witzig, MD, Robert A. Kyle, MD, Stephen Russell, MD, PhD, Nelson Leung, MD, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD

Blood (2012) 120 (21): 946.

https://doi.org/10.1182/blood.V120.21.946.946

Published: 2012

Journal Articles

Continued Improvement in Survival in Multiple Myeloma and the Impact of Novel Agents

Shaji K. Kumar, MD, Angela Dispenzieri, MD, Morie A Gertz, Martha Q Lacy, MD, John A Lust, MD, PhD, Suzanne R Hayman, MD, Francis K Buadi, M.D., David Dingli, M.D., Ph.D., Steven R Zeldenrust, MD, PhD, Stephen Russell, MD, PhD, Prashant Kapoor, MD, Yi Lin, MD, PhD, Lisa Hwa, RN, CNP, Dirk Larson, Colin L. Colby, Joanne T Benson, Robert A. Kyle, MD, S. Vincent Rajkumar, MD

Blood (2012) 120 (21): 3972.

https://doi.org/10.1182/blood.V120.21.3972.3972

Published: 2012

NARROW

Quality of Life and Outcomes in Multiple Myeloma Patients

Phase 2 Trial Of Single Agent MLN9708 In Patients With Relapsed Multiple Myeloma Not Refractory To Bortezomib

Therapeutic Strategies For Initial Treatment Of AL Amyloidosis: Implications Of Therapy and Response On Outcome

Survival After Second, Third, and Fourth Line Therapy Better Than Expected in Patients with Previously Treated AL Amyloidosis Who Were Not Transplant Candidates At Diagnosis.

Continued Improvement in Survival in Multiple Myeloma and the Impact of Novel Agents

Email alerts

ASH Publications

American Society of Hematology

Quality of Life and Outcomes in Multiple Myeloma Patients

Phase 2 Trial Of Single Agent MLN9708 In Patients With Relapsed Multiple Myeloma Not Refractory To Bortezomib

Therapeutic Strategies For Initial Treatment Of AL Amyloidosis: Implications Of Therapy and Response On Outcome

Survival After Second, Third, and Fourth Line Therapy Better Than Expected in Patients with Previously Treated AL Amyloidosis Who Were Not Transplant Candidates At Diagnosis.

Continued Improvement in Survival in Multiple Myeloma and the Impact of Novel Agents

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only